News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
595,392 Results
Type
Article (47289)
Company Profile (203)
Press Release (547900)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (166388)
Career Advice (2580)
Deals (30138)
Drug Delivery (108)
Drug Development (76235)
Employer Resources (155)
FDA (13972)
Job Trends (13291)
News (292307)
Policy (28311)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (2627)
Academic (1)
Accelerated approval (5)
Adcomms (28)
Allergies (79)
Alliances (42814)
ALS (92)
Alzheimer's disease (1418)
Antibody-drug conjugate (ADC) (133)
Approvals (13961)
Artificial intelligence (249)
Autoimmune disease (26)
Automation (15)
Bankruptcy (326)
Best Places to Work (10510)
BIOSECURE Act (20)
Biosimilars (95)
Biotechnology (165)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (256)
Cancer (2076)
Cardiovascular disease (180)
Career advice (2158)
Career pathing (32)
CAR-T (151)
Cell therapy (420)
Cervical cancer (17)
Clinical research (61856)
Collaboration (783)
Compensation (352)
Complete response letters (24)
COVID-19 (2564)
CRISPR (41)
C-suite (239)
Cystic fibrosis (93)
Data (2026)
Decentralized trials (2)
Denatured (14)
Depression (50)
Diabetes (255)
Diagnostics (5910)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (118)
Drug pricing (99)
Drug shortages (23)
Duchenne muscular dystrophy (91)
Earnings (59302)
Editorial (38)
Employer branding (20)
Employer resources (139)
Events (87144)
Executive appointments (707)
FDA (15091)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (703)
Gene editing (103)
Generative AI (20)
Gene therapy (312)
GLP-1 (724)
Government (4216)
Grass and pollen (4)
Guidances (49)
Healthcare (16562)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (129)
Indications (25)
Infectious disease (2710)
Inflammatory bowel disease (136)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (89)
Interviews (530)
IPO (13641)
IRA (47)
Job creations (3178)
Job search strategy (1784)
Kidney cancer (10)
Labor market (27)
Layoffs (461)
Leadership (20)
Legal (6155)
Liver cancer (74)
Lung cancer (310)
Lymphoma (136)
Machine learning (5)
Management (54)
Manufacturing (278)
MASH (69)
Medical device (10757)
Medtech (10761)
Mergers & acquisitions (16977)
Metabolic disorders (674)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (101)
Neuropsychiatric disorders (29)
Neuroscience (1958)
NextGen: Class of 2025 (5854)
Non-profit (4083)
Northern California (2303)
Now hiring (33)
Obesity (355)
Opinion (248)
Ovarian cancer (73)
Pain (90)
Pancreatic cancer (78)
Parkinson's disease (148)
Partnered (20)
Patents (218)
Patient recruitment (100)
Peanut (44)
People (54463)
Pharmaceutical (34)
Pharmacy benefit managers (10)
Phase I (19309)
Phase II (27270)
Phase III (20502)
Pipeline (1114)
Policy (141)
Postmarket research (2364)
Preclinical (7972)
Press Release (69)
Prostate cancer (92)
Psychedelics (38)
Radiopharmaceuticals (233)
Rare diseases (386)
Real estate (5076)
Recruiting (65)
Regulatory (19927)
Reports (30)
Research institute (2244)
Resumes & cover letters (383)
Rett syndrome (4)
RNA editing (3)
RSV (42)
Schizophrenia (74)
Series A (125)
Series B (83)
Service/supplier (11)
Sickle cell disease (55)
Southern California (2030)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (28)
Startups (3328)
State (2)
Stomach cancer (15)
Supply chain (61)
Tariffs (25)
The Weekly (51)
United States (19955)
Vaccines (682)
Venture capitalists (39)
Weight loss (244)
Women's health (27)
Worklife (18)
Date
Today (64)
Last 7 days (435)
Last 30 days (2094)
Last 365 days (30798)
2025 (8737)
2024 (32903)
2023 (36620)
2022 (47328)
2021 (50862)
2020 (48782)
2019 (41692)
2018 (31699)
2017 (29258)
2016 (27960)
2015 (32469)
2014 (26453)
2013 (22586)
2012 (21904)
2011 (22792)
2010 (20386)
Location
Africa (817)
Alabama (49)
Alaska (5)
Arizona (161)
Arkansas (11)
Asia (36893)
Australia (7433)
California (5280)
Canada (1817)
China (487)
Colorado (220)
Connecticut (229)
Delaware (133)
Europe (82702)
Florida (800)
Georgia (170)
Idaho (52)
Illinois (479)
India (25)
Indiana (282)
Iowa (7)
Japan (147)
Kansas (97)
Kentucky (19)
Louisiana (8)
Maine (49)
Maryland (804)
Massachusetts (3855)
Michigan (197)
Minnesota (328)
Mississippi (1)
Missouri (72)
Montana (25)
Nebraska (24)
Nevada (55)
New Hampshire (64)
New Jersey (1527)
New Mexico (25)
New York (1515)
North Carolina (882)
North Dakota (6)
Northern California (2303)
Ohio (171)
Oklahoma (10)
Oregon (29)
Pennsylvania (1136)
Puerto Rico (11)
Rhode Island (29)
South America (1108)
South Carolina (16)
South Dakota (1)
Southern California (2030)
Tennessee (85)
Texas (791)
Utah (166)
Virginia (129)
Washington D.C. (54)
Washington State (516)
West Virginia (3)
Wisconsin (45)
595,392 Results for "fortress biotech formerly known as coronado biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
April 1, 2025
·
18 min read
Press Releases
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
March 18, 2025
·
6 min read
Business
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 15, 2024
·
15 min read
Business
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial results and recent corporate highlights for the full-year ended December 31, 2023.
March 28, 2024
·
14 min read
Press Releases
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
January 6, 2025
·
10 min read
Press Releases
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 15, 2024
·
15 min read
Press Releases
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
January 27, 2025
·
9 min read
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech, Inc. today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company.
May 16, 2024
·
1 min read
Press Releases
Fortress Biotech to Participate in October 2024 Investor Conferences
September 27, 2024
·
2 min read
Fortress Biotech to Participate in 36th Annual ROTH Conference
Fortress Biotech, Inc. today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the 36th Annual ROTH Conference on Monday, March 18, 2024, at 2:00 p.m. PT.
March 12, 2024
·
1 min read
1 of 59,540
Next
